Home | Privacy | Contact    

Health Information About Soft Tissue Sarcoma


Soft Tissue Sarcomas - National Cancer Institute
http://www.cancer.gov/cancertopics/factsheet/sites-types/soft-tissue-sarcoma A fact sheet about soft tissue sarcomas, cancers that develop in tissues that connect, support, or surround other structures and organs of the body. more...
Soft-tissue sarcoma - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Soft_tissue_sarcoma A soft-tissue sarcoma is a form of sarcoma that develops in connective tissue, though the term is sometimes applied to elements of the soft tissue that are not ... more...
Soft-tissue sarcoma: Information from Answers.com
http://www.answers.com/topic/soft-tissue-sarcoma Key Terms: Alveolar rhabdomyosarcoma, Brachytherapy, Cytogenetics, Dermatofibrosarcoma protuberans, Embryonal rhabdomyosarcoma, Epithelioid hemangioendothelioma ... more...
Soft Tissue Sarcoma: MedlinePlus
http://www.nlm.nih.gov/medlineplus/softtissuesarcoma.html Your soft tissues connect, support or surround other tissues. Examples include your muscles, tendons, fat and blood vessels. Soft tissue sarcoma is a cancer of these ... more...
Soft tissue sarcoma - MayoClinic.com - Mayo Clinic
http://www.mayoclinic.com/health/soft-tissue-sarcoma/DS00601/METHOD=print Soft tissue sarcomas — Comprehensive overview covers symptoms, causes, treatment of these uncommon cancers. more...



Soft Tissue Sarcoma News


soft tissue sarcoma - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
ZIOPHARM Reports Palifosfamide Survival Data From Study In
(RTTNews) - ZIOPHARM Oncology, Inc. (ZIOP: News ) announced positive preliminary overall survival, or OS, data from its randomized, controlled Phase 2 trial of palifosfamide plus doxorubicin versus doxorubicin alone, or PICASSO, in patients with ... read more...
ZIOPHARM Oncology Reports Positive Preliminary Palifosfamide Overall Survival Data From Randomized Phase 2 Study in
NEW YORK, Feb. 13, 2012 (GLOBE NEWSWIRE) -- ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company with small molecule and synthetic biology approaches to new cancer therapies, announced today positive preliminary overall survival ... read more...
Battling
read more...

The report is is an essential source of information on read more...